Global Targeted Drugs for NSCLC Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Targeted Drugs for NSCLC Industry Forecast” looks at past sales and reviews total world Targeted Drugs for NSCLC sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for NSCLC sales for 2023 through 2029. With Targeted Drugs for NSCLC sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for NSCLC industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for NSCLC landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Drugs for NSCLC portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for NSCLC market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for NSCLC and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for NSCLC.
The global Targeted Drugs for NSCLC market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Targeted Drugs for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Targeted Drugs for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Targeted Drugs for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Targeted Drugs for NSCLC players cover Allergan, Amgen, ARIAD Pharmaceuticals (Takeda), Beacon Pharma Limited, BeiGene, Biocon, Boehringer-Ingelheim, Celgene Corporation and Drug International Limted, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for NSCLC market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Targeted Drugs for NSCLC Industry Forecast” looks at past sales and reviews total world Targeted Drugs for NSCLC sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for NSCLC sales for 2023 through 2029. With Targeted Drugs for NSCLC sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for NSCLC industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for NSCLC landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Drugs for NSCLC portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for NSCLC market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for NSCLC and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for NSCLC.
The global Targeted Drugs for NSCLC market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Targeted Drugs for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Targeted Drugs for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Targeted Drugs for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Targeted Drugs for NSCLC players cover Allergan, Amgen, ARIAD Pharmaceuticals (Takeda), Beacon Pharma Limited, BeiGene, Biocon, Boehringer-Ingelheim, Celgene Corporation and Drug International Limted, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for NSCLC market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Target EGFR
- Target ALK
- Target HER2
- Target ROS1
- Target BRAF
- Target MEK
- Target VEGFR2
- Target VEGF
- Target MET
- Squamous Cell Carcinoma of NSCLC
- Adenocarcinoma of NSCLC
- Large Cell Carcinoma of NSCLC
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Allergan
- Amgen
- ARIAD Pharmaceuticals (Takeda)
- Beacon Pharma Limited
- BeiGene
- Biocon
- Boehringer-Ingelheim
- Celgene Corporation
- Drug International Limted
- Fujifilm Kyowa Kirin Biologics
- Genvio Pharma Limited
- Hetero Drugs
- ImClone Systems ?(Eli Lilly)
- Incepta Pharmaceuticals
- Mylan
- Novartis
- Pfizer
- Reliance Lifesciences
- Roche
- AstraZeneca
- Cipla
- Teva
- OSI Pharmaceuticals
- Glenmark Pharmaceuticals
- Natco Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drugs for NSCLC Market Size 2018-2029
2.1.2 Targeted Drugs for NSCLC Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Targeted Drugs for NSCLC Segment by Type
2.2.1 Target EGFR
2.2.2 Target ALK
2.2.3 Target HER2
2.2.4 Target ROS1
2.2.5 Target BRAF
2.2.6 Target MEK
2.2.7 Target VEGFR2
2.2.8 Target VEGF
2.2.9 Target MET
2.3 Targeted Drugs for NSCLC Market Size by Type
2.3.1 Targeted Drugs for NSCLC Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
2.4 Targeted Drugs for NSCLC Segment by Application
2.4.1 Squamous Cell Carcinoma of NSCLC
2.4.2 Adenocarcinoma of NSCLC
2.4.3 Large Cell Carcinoma of NSCLC
2.5 Targeted Drugs for NSCLC Market Size by Application
2.5.1 Targeted Drugs for NSCLC Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
3 TARGETED DRUGS FOR NSCLC MARKET SIZE BY PLAYER
3.1 Targeted Drugs for NSCLC Market Size Market Share by Players
3.1.1 Global Targeted Drugs for NSCLC Revenue by Players (2018-2023)
3.1.2 Global Targeted Drugs for NSCLC Revenue Market Share by Players (2018-2023)
3.2 Global Targeted Drugs for NSCLC Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUGS FOR NSCLC BY REGIONS
4.1 Targeted Drugs for NSCLC Market Size by Regions (2018-2023)
4.2 Americas Targeted Drugs for NSCLC Market Size Growth (2018-2023)
4.3 APAC Targeted Drugs for NSCLC Market Size Growth (2018-2023)
4.4 Europe Targeted Drugs for NSCLC Market Size Growth (2018-2023)
4.5 Middle East & Africa Targeted Drugs for NSCLC Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Targeted Drugs for NSCLC Market Size by Country (2018-2023)
5.2 Americas Targeted Drugs for NSCLC Market Size by Type (2018-2023)
5.3 Americas Targeted Drugs for NSCLC Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drugs for NSCLC Market Size by Region (2018-2023)
6.2 APAC Targeted Drugs for NSCLC Market Size by Type (2018-2023)
6.3 APAC Targeted Drugs for NSCLC Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drugs for NSCLC by Country (2018-2023)
7.2 Europe Targeted Drugs for NSCLC Market Size by Type (2018-2023)
7.3 Europe Targeted Drugs for NSCLC Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drugs for NSCLC by Region (2018-2023)
8.2 Middle East & Africa Targeted Drugs for NSCLC Market Size by Type (2018-2023)
8.3 Middle East & Africa Targeted Drugs for NSCLC Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUGS FOR NSCLC MARKET FORECAST
10.1 Global Targeted Drugs for NSCLC Forecast by Regions (2024-2029)
10.1.1 Global Targeted Drugs for NSCLC Forecast by Regions (2024-2029)
10.1.2 Americas Targeted Drugs for NSCLC Forecast
10.1.3 APAC Targeted Drugs for NSCLC Forecast
10.1.4 Europe Targeted Drugs for NSCLC Forecast
10.1.5 Middle East & Africa Targeted Drugs for NSCLC Forecast
10.2 Americas Targeted Drugs for NSCLC Forecast by Country (2024-2029)
10.2.1 United States Targeted Drugs for NSCLC Market Forecast
10.2.2 Canada Targeted Drugs for NSCLC Market Forecast
10.2.3 Mexico Targeted Drugs for NSCLC Market Forecast
10.2.4 Brazil Targeted Drugs for NSCLC Market Forecast
10.3 APAC Targeted Drugs for NSCLC Forecast by Region (2024-2029)
10.3.1 China Targeted Drugs for NSCLC Market Forecast
10.3.2 Japan Targeted Drugs for NSCLC Market Forecast
10.3.3 Korea Targeted Drugs for NSCLC Market Forecast
10.3.4 Southeast Asia Targeted Drugs for NSCLC Market Forecast
10.3.5 India Targeted Drugs for NSCLC Market Forecast
10.3.6 Australia Targeted Drugs for NSCLC Market Forecast
10.4 Europe Targeted Drugs for NSCLC Forecast by Country (2024-2029)
10.4.1 Germany Targeted Drugs for NSCLC Market Forecast
10.4.2 France Targeted Drugs for NSCLC Market Forecast
10.4.3 UK Targeted Drugs for NSCLC Market Forecast
10.4.4 Italy Targeted Drugs for NSCLC Market Forecast
10.4.5 Russia Targeted Drugs for NSCLC Market Forecast
10.5 Middle East & Africa Targeted Drugs for NSCLC Forecast by Region (2024-2029)
10.5.1 Egypt Targeted Drugs for NSCLC Market Forecast
10.5.2 South Africa Targeted Drugs for NSCLC Market Forecast
10.5.3 Israel Targeted Drugs for NSCLC Market Forecast
10.5.4 Turkey Targeted Drugs for NSCLC Market Forecast
10.5.5 GCC Countries Targeted Drugs for NSCLC Market Forecast
10.6 Global Targeted Drugs for NSCLC Forecast by Type (2024-2029)
10.7 Global Targeted Drugs for NSCLC Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Targeted Drugs for NSCLC Product Offered
11.1.3 Allergan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Allergan Main Business Overview
11.1.5 Allergan Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Targeted Drugs for NSCLC Product Offered
11.2.3 Amgen Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 ARIAD Pharmaceuticals (Takeda)
11.3.1 ARIAD Pharmaceuticals (Takeda) Company Information
11.3.2 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Offered
11.3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 ARIAD Pharmaceuticals (Takeda) Main Business Overview
11.3.5 ARIAD Pharmaceuticals (Takeda) Latest Developments
11.4 Beacon Pharma Limited
11.4.1 Beacon Pharma Limited Company Information
11.4.2 Beacon Pharma Limited Targeted Drugs for NSCLC Product Offered
11.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Beacon Pharma Limited Main Business Overview
11.4.5 Beacon Pharma Limited Latest Developments
11.5 BeiGene
11.5.1 BeiGene Company Information
11.5.2 BeiGene Targeted Drugs for NSCLC Product Offered
11.5.3 BeiGene Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BeiGene Main Business Overview
11.5.5 BeiGene Latest Developments
11.6 Biocon
11.6.1 Biocon Company Information
11.6.2 Biocon Targeted Drugs for NSCLC Product Offered
11.6.3 Biocon Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Biocon Main Business Overview
11.6.5 Biocon Latest Developments
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Information
11.7.2 Boehringer-Ingelheim Targeted Drugs for NSCLC Product Offered
11.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Boehringer-Ingelheim Main Business Overview
11.7.5 Boehringer-Ingelheim Latest Developments
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Information
11.8.2 Celgene Corporation Targeted Drugs for NSCLC Product Offered
11.8.3 Celgene Corporation Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Celgene Corporation Main Business Overview
11.8.5 Celgene Corporation Latest Developments
11.9 Drug International Limted
11.9.1 Drug International Limted Company Information
11.9.2 Drug International Limted Targeted Drugs for NSCLC Product Offered
11.9.3 Drug International Limted Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Drug International Limted Main Business Overview
11.9.5 Drug International Limted Latest Developments
11.10 Fujifilm Kyowa Kirin Biologics
11.10.1 Fujifilm Kyowa Kirin Biologics Company Information
11.10.2 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Offered
11.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Fujifilm Kyowa Kirin Biologics Main Business Overview
11.10.5 Fujifilm Kyowa Kirin Biologics Latest Developments
11.11 Genvio Pharma Limited
11.11.1 Genvio Pharma Limited Company Information
11.11.2 Genvio Pharma Limited Targeted Drugs for NSCLC Product Offered
11.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Genvio Pharma Limited Main Business Overview
11.11.5 Genvio Pharma Limited Latest Developments
11.12 Hetero Drugs
11.12.1 Hetero Drugs Company Information
11.12.2 Hetero Drugs Targeted Drugs for NSCLC Product Offered
11.12.3 Hetero Drugs Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Hetero Drugs Main Business Overview
11.12.5 Hetero Drugs Latest Developments
11.13 ImClone Systems ?(Eli Lilly)
11.13.1 ImClone Systems ?(Eli Lilly) Company Information
11.13.2 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Product Offered
11.13.3 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 ImClone Systems ?(Eli Lilly) Main Business Overview
11.13.5 ImClone Systems ?(Eli Lilly) Latest Developments
11.14 Incepta Pharmaceuticals
11.14.1 Incepta Pharmaceuticals Company Information
11.14.2 Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.14.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Incepta Pharmaceuticals Main Business Overview
11.14.5 Incepta Pharmaceuticals Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Targeted Drugs for NSCLC Product Offered
11.15.3 Mylan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Novartis
11.16.1 Novartis Company Information
11.16.2 Novartis Targeted Drugs for NSCLC Product Offered
11.16.3 Novartis Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Novartis Main Business Overview
11.16.5 Novartis Latest Developments
11.17 Pfizer
11.17.1 Pfizer Company Information
11.17.2 Pfizer Targeted Drugs for NSCLC Product Offered
11.17.3 Pfizer Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Pfizer Main Business Overview
11.17.5 Pfizer Latest Developments
11.18 Reliance Lifesciences
11.18.1 Reliance Lifesciences Company Information
11.18.2 Reliance Lifesciences Targeted Drugs for NSCLC Product Offered
11.18.3 Reliance Lifesciences Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Reliance Lifesciences Main Business Overview
11.18.5 Reliance Lifesciences Latest Developments
11.19 Roche
11.19.1 Roche Company Information
11.19.2 Roche Targeted Drugs for NSCLC Product Offered
11.19.3 Roche Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Roche Main Business Overview
11.19.5 Roche Latest Developments
11.20 AstraZeneca
11.20.1 AstraZeneca Company Information
11.20.2 AstraZeneca Targeted Drugs for NSCLC Product Offered
11.20.3 AstraZeneca Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 AstraZeneca Main Business Overview
11.20.5 AstraZeneca Latest Developments
11.21 Cipla
11.21.1 Cipla Company Information
11.21.2 Cipla Targeted Drugs for NSCLC Product Offered
11.21.3 Cipla Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Cipla Main Business Overview
11.21.5 Cipla Latest Developments
11.22 Teva
11.22.1 Teva Company Information
11.22.2 Teva Targeted Drugs for NSCLC Product Offered
11.22.3 Teva Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Teva Main Business Overview
11.22.5 Teva Latest Developments
11.23 OSI Pharmaceuticals
11.23.1 OSI Pharmaceuticals Company Information
11.23.2 OSI Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.23.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 OSI Pharmaceuticals Main Business Overview
11.23.5 OSI Pharmaceuticals Latest Developments
11.24 Glenmark Pharmaceuticals
11.24.1 Glenmark Pharmaceuticals Company Information
11.24.2 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.24.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Glenmark Pharmaceuticals Main Business Overview
11.24.5 Glenmark Pharmaceuticals Latest Developments
11.25 Natco Pharma
11.25.1 Natco Pharma Company Information
11.25.2 Natco Pharma Targeted Drugs for NSCLC Product Offered
11.25.3 Natco Pharma Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Natco Pharma Main Business Overview
11.25.5 Natco Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drugs for NSCLC Market Size 2018-2029
2.1.2 Targeted Drugs for NSCLC Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Targeted Drugs for NSCLC Segment by Type
2.2.1 Target EGFR
2.2.2 Target ALK
2.2.3 Target HER2
2.2.4 Target ROS1
2.2.5 Target BRAF
2.2.6 Target MEK
2.2.7 Target VEGFR2
2.2.8 Target VEGF
2.2.9 Target MET
2.3 Targeted Drugs for NSCLC Market Size by Type
2.3.1 Targeted Drugs for NSCLC Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
2.4 Targeted Drugs for NSCLC Segment by Application
2.4.1 Squamous Cell Carcinoma of NSCLC
2.4.2 Adenocarcinoma of NSCLC
2.4.3 Large Cell Carcinoma of NSCLC
2.5 Targeted Drugs for NSCLC Market Size by Application
2.5.1 Targeted Drugs for NSCLC Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
3 TARGETED DRUGS FOR NSCLC MARKET SIZE BY PLAYER
3.1 Targeted Drugs for NSCLC Market Size Market Share by Players
3.1.1 Global Targeted Drugs for NSCLC Revenue by Players (2018-2023)
3.1.2 Global Targeted Drugs for NSCLC Revenue Market Share by Players (2018-2023)
3.2 Global Targeted Drugs for NSCLC Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUGS FOR NSCLC BY REGIONS
4.1 Targeted Drugs for NSCLC Market Size by Regions (2018-2023)
4.2 Americas Targeted Drugs for NSCLC Market Size Growth (2018-2023)
4.3 APAC Targeted Drugs for NSCLC Market Size Growth (2018-2023)
4.4 Europe Targeted Drugs for NSCLC Market Size Growth (2018-2023)
4.5 Middle East & Africa Targeted Drugs for NSCLC Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Targeted Drugs for NSCLC Market Size by Country (2018-2023)
5.2 Americas Targeted Drugs for NSCLC Market Size by Type (2018-2023)
5.3 Americas Targeted Drugs for NSCLC Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drugs for NSCLC Market Size by Region (2018-2023)
6.2 APAC Targeted Drugs for NSCLC Market Size by Type (2018-2023)
6.3 APAC Targeted Drugs for NSCLC Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drugs for NSCLC by Country (2018-2023)
7.2 Europe Targeted Drugs for NSCLC Market Size by Type (2018-2023)
7.3 Europe Targeted Drugs for NSCLC Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drugs for NSCLC by Region (2018-2023)
8.2 Middle East & Africa Targeted Drugs for NSCLC Market Size by Type (2018-2023)
8.3 Middle East & Africa Targeted Drugs for NSCLC Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUGS FOR NSCLC MARKET FORECAST
10.1 Global Targeted Drugs for NSCLC Forecast by Regions (2024-2029)
10.1.1 Global Targeted Drugs for NSCLC Forecast by Regions (2024-2029)
10.1.2 Americas Targeted Drugs for NSCLC Forecast
10.1.3 APAC Targeted Drugs for NSCLC Forecast
10.1.4 Europe Targeted Drugs for NSCLC Forecast
10.1.5 Middle East & Africa Targeted Drugs for NSCLC Forecast
10.2 Americas Targeted Drugs for NSCLC Forecast by Country (2024-2029)
10.2.1 United States Targeted Drugs for NSCLC Market Forecast
10.2.2 Canada Targeted Drugs for NSCLC Market Forecast
10.2.3 Mexico Targeted Drugs for NSCLC Market Forecast
10.2.4 Brazil Targeted Drugs for NSCLC Market Forecast
10.3 APAC Targeted Drugs for NSCLC Forecast by Region (2024-2029)
10.3.1 China Targeted Drugs for NSCLC Market Forecast
10.3.2 Japan Targeted Drugs for NSCLC Market Forecast
10.3.3 Korea Targeted Drugs for NSCLC Market Forecast
10.3.4 Southeast Asia Targeted Drugs for NSCLC Market Forecast
10.3.5 India Targeted Drugs for NSCLC Market Forecast
10.3.6 Australia Targeted Drugs for NSCLC Market Forecast
10.4 Europe Targeted Drugs for NSCLC Forecast by Country (2024-2029)
10.4.1 Germany Targeted Drugs for NSCLC Market Forecast
10.4.2 France Targeted Drugs for NSCLC Market Forecast
10.4.3 UK Targeted Drugs for NSCLC Market Forecast
10.4.4 Italy Targeted Drugs for NSCLC Market Forecast
10.4.5 Russia Targeted Drugs for NSCLC Market Forecast
10.5 Middle East & Africa Targeted Drugs for NSCLC Forecast by Region (2024-2029)
10.5.1 Egypt Targeted Drugs for NSCLC Market Forecast
10.5.2 South Africa Targeted Drugs for NSCLC Market Forecast
10.5.3 Israel Targeted Drugs for NSCLC Market Forecast
10.5.4 Turkey Targeted Drugs for NSCLC Market Forecast
10.5.5 GCC Countries Targeted Drugs for NSCLC Market Forecast
10.6 Global Targeted Drugs for NSCLC Forecast by Type (2024-2029)
10.7 Global Targeted Drugs for NSCLC Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Targeted Drugs for NSCLC Product Offered
11.1.3 Allergan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Allergan Main Business Overview
11.1.5 Allergan Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Targeted Drugs for NSCLC Product Offered
11.2.3 Amgen Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 ARIAD Pharmaceuticals (Takeda)
11.3.1 ARIAD Pharmaceuticals (Takeda) Company Information
11.3.2 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Offered
11.3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 ARIAD Pharmaceuticals (Takeda) Main Business Overview
11.3.5 ARIAD Pharmaceuticals (Takeda) Latest Developments
11.4 Beacon Pharma Limited
11.4.1 Beacon Pharma Limited Company Information
11.4.2 Beacon Pharma Limited Targeted Drugs for NSCLC Product Offered
11.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Beacon Pharma Limited Main Business Overview
11.4.5 Beacon Pharma Limited Latest Developments
11.5 BeiGene
11.5.1 BeiGene Company Information
11.5.2 BeiGene Targeted Drugs for NSCLC Product Offered
11.5.3 BeiGene Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BeiGene Main Business Overview
11.5.5 BeiGene Latest Developments
11.6 Biocon
11.6.1 Biocon Company Information
11.6.2 Biocon Targeted Drugs for NSCLC Product Offered
11.6.3 Biocon Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Biocon Main Business Overview
11.6.5 Biocon Latest Developments
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Information
11.7.2 Boehringer-Ingelheim Targeted Drugs for NSCLC Product Offered
11.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Boehringer-Ingelheim Main Business Overview
11.7.5 Boehringer-Ingelheim Latest Developments
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Information
11.8.2 Celgene Corporation Targeted Drugs for NSCLC Product Offered
11.8.3 Celgene Corporation Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Celgene Corporation Main Business Overview
11.8.5 Celgene Corporation Latest Developments
11.9 Drug International Limted
11.9.1 Drug International Limted Company Information
11.9.2 Drug International Limted Targeted Drugs for NSCLC Product Offered
11.9.3 Drug International Limted Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Drug International Limted Main Business Overview
11.9.5 Drug International Limted Latest Developments
11.10 Fujifilm Kyowa Kirin Biologics
11.10.1 Fujifilm Kyowa Kirin Biologics Company Information
11.10.2 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Offered
11.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Fujifilm Kyowa Kirin Biologics Main Business Overview
11.10.5 Fujifilm Kyowa Kirin Biologics Latest Developments
11.11 Genvio Pharma Limited
11.11.1 Genvio Pharma Limited Company Information
11.11.2 Genvio Pharma Limited Targeted Drugs for NSCLC Product Offered
11.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Genvio Pharma Limited Main Business Overview
11.11.5 Genvio Pharma Limited Latest Developments
11.12 Hetero Drugs
11.12.1 Hetero Drugs Company Information
11.12.2 Hetero Drugs Targeted Drugs for NSCLC Product Offered
11.12.3 Hetero Drugs Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Hetero Drugs Main Business Overview
11.12.5 Hetero Drugs Latest Developments
11.13 ImClone Systems ?(Eli Lilly)
11.13.1 ImClone Systems ?(Eli Lilly) Company Information
11.13.2 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Product Offered
11.13.3 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 ImClone Systems ?(Eli Lilly) Main Business Overview
11.13.5 ImClone Systems ?(Eli Lilly) Latest Developments
11.14 Incepta Pharmaceuticals
11.14.1 Incepta Pharmaceuticals Company Information
11.14.2 Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.14.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Incepta Pharmaceuticals Main Business Overview
11.14.5 Incepta Pharmaceuticals Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Targeted Drugs for NSCLC Product Offered
11.15.3 Mylan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Novartis
11.16.1 Novartis Company Information
11.16.2 Novartis Targeted Drugs for NSCLC Product Offered
11.16.3 Novartis Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Novartis Main Business Overview
11.16.5 Novartis Latest Developments
11.17 Pfizer
11.17.1 Pfizer Company Information
11.17.2 Pfizer Targeted Drugs for NSCLC Product Offered
11.17.3 Pfizer Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Pfizer Main Business Overview
11.17.5 Pfizer Latest Developments
11.18 Reliance Lifesciences
11.18.1 Reliance Lifesciences Company Information
11.18.2 Reliance Lifesciences Targeted Drugs for NSCLC Product Offered
11.18.3 Reliance Lifesciences Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Reliance Lifesciences Main Business Overview
11.18.5 Reliance Lifesciences Latest Developments
11.19 Roche
11.19.1 Roche Company Information
11.19.2 Roche Targeted Drugs for NSCLC Product Offered
11.19.3 Roche Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Roche Main Business Overview
11.19.5 Roche Latest Developments
11.20 AstraZeneca
11.20.1 AstraZeneca Company Information
11.20.2 AstraZeneca Targeted Drugs for NSCLC Product Offered
11.20.3 AstraZeneca Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 AstraZeneca Main Business Overview
11.20.5 AstraZeneca Latest Developments
11.21 Cipla
11.21.1 Cipla Company Information
11.21.2 Cipla Targeted Drugs for NSCLC Product Offered
11.21.3 Cipla Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Cipla Main Business Overview
11.21.5 Cipla Latest Developments
11.22 Teva
11.22.1 Teva Company Information
11.22.2 Teva Targeted Drugs for NSCLC Product Offered
11.22.3 Teva Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Teva Main Business Overview
11.22.5 Teva Latest Developments
11.23 OSI Pharmaceuticals
11.23.1 OSI Pharmaceuticals Company Information
11.23.2 OSI Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.23.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 OSI Pharmaceuticals Main Business Overview
11.23.5 OSI Pharmaceuticals Latest Developments
11.24 Glenmark Pharmaceuticals
11.24.1 Glenmark Pharmaceuticals Company Information
11.24.2 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.24.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Glenmark Pharmaceuticals Main Business Overview
11.24.5 Glenmark Pharmaceuticals Latest Developments
11.25 Natco Pharma
11.25.1 Natco Pharma Company Information
11.25.2 Natco Pharma Targeted Drugs for NSCLC Product Offered
11.25.3 Natco Pharma Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Natco Pharma Main Business Overview
11.25.5 Natco Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Drugs for NSCLC Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Target EGFR
Table 3. Major Players of Target ALK
Table 4. Major Players of Target HER2
Table 5. Major Players of Target ROS1
Table 6. Major Players of Target BRAF
Table 7. Major Players of Target MEK
Table 8. Major Players of Target VEGFR2
Table 9. Major Players of Target VEGF
Table 10. Major Players of Target MET
Table 11. Targeted Drugs for NSCLC Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 13. Global Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 14. Targeted Drugs for NSCLC Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 15. Global Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 16. Global Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 17. Global Targeted Drugs for NSCLC Revenue by Players (2018-2023) & ($ Millions)
Table 18. Global Targeted Drugs for NSCLC Revenue Market Share by Player (2018-2023)
Table 19. Targeted Drugs for NSCLC Key Players Head office and Products Offered
Table 20. Targeted Drugs for NSCLC Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Targeted Drugs for NSCLC Market Size by Regions 2018-2023 & ($ Millions)
Table 24. Global Targeted Drugs for NSCLC Market Size Market Share by Regions (2018-2023)
Table 25. Global Targeted Drugs for NSCLC Revenue by Country/Region (2018-2023) & ($ millions)
Table 26. Global Targeted Drugs for NSCLC Revenue Market Share by Country/Region (2018-2023)
Table 27. Americas Targeted Drugs for NSCLC Market Size by Country (2018-2023) & ($ Millions)
Table 28. Americas Targeted Drugs for NSCLC Market Size Market Share by Country (2018-2023)
Table 29. Americas Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 30. Americas Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 31. Americas Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 32. Americas Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 33. APAC Targeted Drugs for NSCLC Market Size by Region (2018-2023) & ($ Millions)
Table 34. APAC Targeted Drugs for NSCLC Market Size Market Share by Region (2018-2023)
Table 35. APAC Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 36. APAC Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 37. APAC Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 38. APAC Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 39. Europe Targeted Drugs for NSCLC Market Size by Country (2018-2023) & ($ Millions)
Table 40. Europe Targeted Drugs for NSCLC Market Size Market Share by Country (2018-2023)
Table 41. Europe Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 42. Europe Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 43. Europe Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 44. Europe Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 45. Middle East & Africa Targeted Drugs for NSCLC Market Size by Region (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Region (2018-2023)
Table 47. Middle East & Africa Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 49. Middle East & Africa Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 50. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 51. Key Market Drivers & Growth Opportunities of Targeted Drugs for NSCLC
Table 52. Key Market Challenges & Risks of Targeted Drugs for NSCLC
Table 53. Key Industry Trends of Targeted Drugs for NSCLC
Table 54. Global Targeted Drugs for NSCLC Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 55. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Regions (2024-2029)
Table 56. Global Targeted Drugs for NSCLC Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 57. Global Targeted Drugs for NSCLC Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 58. Allergan Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 59. Allergan Targeted Drugs for NSCLC Product Offered
Table 60. Allergan Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Allergan Main Business
Table 62. Allergan Latest Developments
Table 63. Amgen Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 64. Amgen Targeted Drugs for NSCLC Product Offered
Table 65. Amgen Main Business
Table 66. Amgen Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Amgen Latest Developments
Table 68. ARIAD Pharmaceuticals (Takeda) Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 69. ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Offered
Table 70. ARIAD Pharmaceuticals (Takeda) Main Business
Table 71. ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. ARIAD Pharmaceuticals (Takeda) Latest Developments
Table 73. Beacon Pharma Limited Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 74. Beacon Pharma Limited Targeted Drugs for NSCLC Product Offered
Table 75. Beacon Pharma Limited Main Business
Table 76. Beacon Pharma Limited Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Beacon Pharma Limited Latest Developments
Table 78. BeiGene Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 79. BeiGene Targeted Drugs for NSCLC Product Offered
Table 80. BeiGene Main Business
Table 81. BeiGene Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. BeiGene Latest Developments
Table 83. Biocon Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 84. Biocon Targeted Drugs for NSCLC Product Offered
Table 85. Biocon Main Business
Table 86. Biocon Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Biocon Latest Developments
Table 88. Boehringer-Ingelheim Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 89. Boehringer-Ingelheim Targeted Drugs for NSCLC Product Offered
Table 90. Boehringer-Ingelheim Main Business
Table 91. Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Boehringer-Ingelheim Latest Developments
Table 93. Celgene Corporation Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 94. Celgene Corporation Targeted Drugs for NSCLC Product Offered
Table 95. Celgene Corporation Main Business
Table 96. Celgene Corporation Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Celgene Corporation Latest Developments
Table 98. Drug International Limted Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 99. Drug International Limted Targeted Drugs for NSCLC Product Offered
Table 100. Drug International Limted Main Business
Table 101. Drug International Limted Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Drug International Limted Latest Developments
Table 103. Fujifilm Kyowa Kirin Biologics Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 104. Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Offered
Table 105. Fujifilm Kyowa Kirin Biologics Main Business
Table 106. Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Fujifilm Kyowa Kirin Biologics Latest Developments
Table 108. Genvio Pharma Limited Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 109. Genvio Pharma Limited Targeted Drugs for NSCLC Product Offered
Table 110. Genvio Pharma Limited Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Genvio Pharma Limited Main Business
Table 112. Genvio Pharma Limited Latest Developments
Table 113. Hetero Drugs Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 114. Hetero Drugs Targeted Drugs for NSCLC Product Offered
Table 115. Hetero Drugs Main Business
Table 116. Hetero Drugs Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Hetero Drugs Latest Developments
Table 118. ImClone Systems ?(Eli Lilly) Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 119. ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Product Offered
Table 120. ImClone Systems ?(Eli Lilly) Main Business
Table 121. ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. ImClone Systems ?(Eli Lilly) Latest Developments
Table 123. Incepta Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 124. Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 125. Incepta Pharmaceuticals Main Business
Table 126. Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Incepta Pharmaceuticals Latest Developments
Table 128. Mylan Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 129. Mylan Targeted Drugs for NSCLC Product Offered
Table 130. Mylan Main Business
Table 131. Mylan Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Mylan Latest Developments
Table 133. Novartis Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 134. Novartis Targeted Drugs for NSCLC Product Offered
Table 135. Novartis Main Business
Table 136. Novartis Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Novartis Latest Developments
Table 138. Pfizer Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 139. Pfizer Targeted Drugs for NSCLC Product Offered
Table 140. Pfizer Main Business
Table 141. Pfizer Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. Pfizer Latest Developments
Table 143. Reliance Lifesciences Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 144. Reliance Lifesciences Targeted Drugs for NSCLC Product Offered
Table 145. Reliance Lifesciences Main Business
Table 146. Reliance Lifesciences Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Reliance Lifesciences Latest Developments
Table 148. Roche Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 149. Roche Targeted Drugs for NSCLC Product Offered
Table 150. Roche Main Business
Table 151. Roche Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. Roche Latest Developments
Table 153. AstraZeneca Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 154. AstraZeneca Targeted Drugs for NSCLC Product Offered
Table 155. AstraZeneca Main Business
Table 156. AstraZeneca Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 157. AstraZeneca Latest Developments
Table 158. Cipla Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 159. Cipla Targeted Drugs for NSCLC Product Offered
Table 160. Cipla Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. Cipla Main Business
Table 162. Cipla Latest Developments
Table 163. Teva Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 164. Teva Targeted Drugs for NSCLC Product Offered
Table 165. Teva Main Business
Table 166. Teva Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 167. Teva Latest Developments
Table 168. OSI Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 169. OSI Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 170. OSI Pharmaceuticals Main Business
Table 171. OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 172. OSI Pharmaceuticals Latest Developments
Table 173. Glenmark Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 174. Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 175. Glenmark Pharmaceuticals Main Business
Table 176. Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 177. Glenmark Pharmaceuticals Latest Developments
Table 178. Natco Pharma Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 179. Natco Pharma Targeted Drugs for NSCLC Product Offered
Table 180. Natco Pharma Main Business
Table 181. Natco Pharma Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 182. Natco Pharma Latest Developments
Table 1. Targeted Drugs for NSCLC Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Target EGFR
Table 3. Major Players of Target ALK
Table 4. Major Players of Target HER2
Table 5. Major Players of Target ROS1
Table 6. Major Players of Target BRAF
Table 7. Major Players of Target MEK
Table 8. Major Players of Target VEGFR2
Table 9. Major Players of Target VEGF
Table 10. Major Players of Target MET
Table 11. Targeted Drugs for NSCLC Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 13. Global Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 14. Targeted Drugs for NSCLC Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 15. Global Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 16. Global Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 17. Global Targeted Drugs for NSCLC Revenue by Players (2018-2023) & ($ Millions)
Table 18. Global Targeted Drugs for NSCLC Revenue Market Share by Player (2018-2023)
Table 19. Targeted Drugs for NSCLC Key Players Head office and Products Offered
Table 20. Targeted Drugs for NSCLC Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Targeted Drugs for NSCLC Market Size by Regions 2018-2023 & ($ Millions)
Table 24. Global Targeted Drugs for NSCLC Market Size Market Share by Regions (2018-2023)
Table 25. Global Targeted Drugs for NSCLC Revenue by Country/Region (2018-2023) & ($ millions)
Table 26. Global Targeted Drugs for NSCLC Revenue Market Share by Country/Region (2018-2023)
Table 27. Americas Targeted Drugs for NSCLC Market Size by Country (2018-2023) & ($ Millions)
Table 28. Americas Targeted Drugs for NSCLC Market Size Market Share by Country (2018-2023)
Table 29. Americas Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 30. Americas Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 31. Americas Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 32. Americas Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 33. APAC Targeted Drugs for NSCLC Market Size by Region (2018-2023) & ($ Millions)
Table 34. APAC Targeted Drugs for NSCLC Market Size Market Share by Region (2018-2023)
Table 35. APAC Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 36. APAC Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 37. APAC Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 38. APAC Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 39. Europe Targeted Drugs for NSCLC Market Size by Country (2018-2023) & ($ Millions)
Table 40. Europe Targeted Drugs for NSCLC Market Size Market Share by Country (2018-2023)
Table 41. Europe Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 42. Europe Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 43. Europe Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 44. Europe Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 45. Middle East & Africa Targeted Drugs for NSCLC Market Size by Region (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Region (2018-2023)
Table 47. Middle East & Africa Targeted Drugs for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Table 49. Middle East & Africa Targeted Drugs for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 50. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Table 51. Key Market Drivers & Growth Opportunities of Targeted Drugs for NSCLC
Table 52. Key Market Challenges & Risks of Targeted Drugs for NSCLC
Table 53. Key Industry Trends of Targeted Drugs for NSCLC
Table 54. Global Targeted Drugs for NSCLC Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 55. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Regions (2024-2029)
Table 56. Global Targeted Drugs for NSCLC Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 57. Global Targeted Drugs for NSCLC Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 58. Allergan Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 59. Allergan Targeted Drugs for NSCLC Product Offered
Table 60. Allergan Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Allergan Main Business
Table 62. Allergan Latest Developments
Table 63. Amgen Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 64. Amgen Targeted Drugs for NSCLC Product Offered
Table 65. Amgen Main Business
Table 66. Amgen Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Amgen Latest Developments
Table 68. ARIAD Pharmaceuticals (Takeda) Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 69. ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Offered
Table 70. ARIAD Pharmaceuticals (Takeda) Main Business
Table 71. ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. ARIAD Pharmaceuticals (Takeda) Latest Developments
Table 73. Beacon Pharma Limited Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 74. Beacon Pharma Limited Targeted Drugs for NSCLC Product Offered
Table 75. Beacon Pharma Limited Main Business
Table 76. Beacon Pharma Limited Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Beacon Pharma Limited Latest Developments
Table 78. BeiGene Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 79. BeiGene Targeted Drugs for NSCLC Product Offered
Table 80. BeiGene Main Business
Table 81. BeiGene Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. BeiGene Latest Developments
Table 83. Biocon Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 84. Biocon Targeted Drugs for NSCLC Product Offered
Table 85. Biocon Main Business
Table 86. Biocon Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Biocon Latest Developments
Table 88. Boehringer-Ingelheim Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 89. Boehringer-Ingelheim Targeted Drugs for NSCLC Product Offered
Table 90. Boehringer-Ingelheim Main Business
Table 91. Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Boehringer-Ingelheim Latest Developments
Table 93. Celgene Corporation Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 94. Celgene Corporation Targeted Drugs for NSCLC Product Offered
Table 95. Celgene Corporation Main Business
Table 96. Celgene Corporation Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Celgene Corporation Latest Developments
Table 98. Drug International Limted Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 99. Drug International Limted Targeted Drugs for NSCLC Product Offered
Table 100. Drug International Limted Main Business
Table 101. Drug International Limted Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Drug International Limted Latest Developments
Table 103. Fujifilm Kyowa Kirin Biologics Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 104. Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Offered
Table 105. Fujifilm Kyowa Kirin Biologics Main Business
Table 106. Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Fujifilm Kyowa Kirin Biologics Latest Developments
Table 108. Genvio Pharma Limited Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 109. Genvio Pharma Limited Targeted Drugs for NSCLC Product Offered
Table 110. Genvio Pharma Limited Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Genvio Pharma Limited Main Business
Table 112. Genvio Pharma Limited Latest Developments
Table 113. Hetero Drugs Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 114. Hetero Drugs Targeted Drugs for NSCLC Product Offered
Table 115. Hetero Drugs Main Business
Table 116. Hetero Drugs Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Hetero Drugs Latest Developments
Table 118. ImClone Systems ?(Eli Lilly) Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 119. ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Product Offered
Table 120. ImClone Systems ?(Eli Lilly) Main Business
Table 121. ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. ImClone Systems ?(Eli Lilly) Latest Developments
Table 123. Incepta Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 124. Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 125. Incepta Pharmaceuticals Main Business
Table 126. Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Incepta Pharmaceuticals Latest Developments
Table 128. Mylan Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 129. Mylan Targeted Drugs for NSCLC Product Offered
Table 130. Mylan Main Business
Table 131. Mylan Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Mylan Latest Developments
Table 133. Novartis Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 134. Novartis Targeted Drugs for NSCLC Product Offered
Table 135. Novartis Main Business
Table 136. Novartis Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Novartis Latest Developments
Table 138. Pfizer Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 139. Pfizer Targeted Drugs for NSCLC Product Offered
Table 140. Pfizer Main Business
Table 141. Pfizer Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. Pfizer Latest Developments
Table 143. Reliance Lifesciences Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 144. Reliance Lifesciences Targeted Drugs for NSCLC Product Offered
Table 145. Reliance Lifesciences Main Business
Table 146. Reliance Lifesciences Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Reliance Lifesciences Latest Developments
Table 148. Roche Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 149. Roche Targeted Drugs for NSCLC Product Offered
Table 150. Roche Main Business
Table 151. Roche Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. Roche Latest Developments
Table 153. AstraZeneca Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 154. AstraZeneca Targeted Drugs for NSCLC Product Offered
Table 155. AstraZeneca Main Business
Table 156. AstraZeneca Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 157. AstraZeneca Latest Developments
Table 158. Cipla Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 159. Cipla Targeted Drugs for NSCLC Product Offered
Table 160. Cipla Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. Cipla Main Business
Table 162. Cipla Latest Developments
Table 163. Teva Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 164. Teva Targeted Drugs for NSCLC Product Offered
Table 165. Teva Main Business
Table 166. Teva Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 167. Teva Latest Developments
Table 168. OSI Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 169. OSI Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 170. OSI Pharmaceuticals Main Business
Table 171. OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 172. OSI Pharmaceuticals Latest Developments
Table 173. Glenmark Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 174. Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 175. Glenmark Pharmaceuticals Main Business
Table 176. Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 177. Glenmark Pharmaceuticals Latest Developments
Table 178. Natco Pharma Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 179. Natco Pharma Targeted Drugs for NSCLC Product Offered
Table 180. Natco Pharma Main Business
Table 181. Natco Pharma Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 182. Natco Pharma Latest Developments
LIST OF FIGURES
Figure 1. Targeted Drugs for NSCLC Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drugs for NSCLC Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Targeted Drugs for NSCLC Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Targeted Drugs for NSCLC Sales Market Share by Country/Region (2022)
Figure 8. Targeted Drugs for NSCLC Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Targeted Drugs for NSCLC Market Size Market Share by Type in 2022
Figure 10. Targeted Drugs for NSCLC in Squamous Cell Carcinoma of NSCLC
Figure 11. Global Targeted Drugs for NSCLC Market: Squamous Cell Carcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 12. Targeted Drugs for NSCLC in Adenocarcinoma of NSCLC
Figure 13. Global Targeted Drugs for NSCLC Market: Adenocarcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 14. Targeted Drugs for NSCLC in Large Cell Carcinoma of NSCLC
Figure 15. Global Targeted Drugs for NSCLC Market: Large Cell Carcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 16. Global Targeted Drugs for NSCLC Market Size Market Share by Application in 2022
Figure 17. Global Targeted Drugs for NSCLC Revenue Market Share by Player in 2022
Figure 18. Global Targeted Drugs for NSCLC Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Targeted Drugs for NSCLC Market Size 2018-2023 ($ Millions)
Figure 20. APAC Targeted Drugs for NSCLC Market Size 2018-2023 ($ Millions)
Figure 21. Europe Targeted Drugs for NSCLC Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Targeted Drugs for NSCLC Market Size 2018-2023 ($ Millions)
Figure 23. Americas Targeted Drugs for NSCLC Value Market Share by Country in 2022
Figure 24. United States Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Targeted Drugs for NSCLC Market Size Market Share by Region in 2022
Figure 29. APAC Targeted Drugs for NSCLC Market Size Market Share by Type in 2022
Figure 30. APAC Targeted Drugs for NSCLC Market Size Market Share by Application in 2022
Figure 31. China Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Targeted Drugs for NSCLC Market Size Market Share by Country in 2022
Figure 38. Europe Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Figure 39. Europe Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Figure 40. Germany Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 54. APAC Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 55. Europe Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 57. United States Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 58. Canada Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 61. China Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 62. Japan Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 63. Korea Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 65. India Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 66. Australia Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 67. Germany Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 68. France Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 69. UK Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 70. Italy Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 71. Russia Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 72. Spain Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 75. Israel Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 78. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Targeted Drugs for NSCLC Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drugs for NSCLC Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Targeted Drugs for NSCLC Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Targeted Drugs for NSCLC Sales Market Share by Country/Region (2022)
Figure 8. Targeted Drugs for NSCLC Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Targeted Drugs for NSCLC Market Size Market Share by Type in 2022
Figure 10. Targeted Drugs for NSCLC in Squamous Cell Carcinoma of NSCLC
Figure 11. Global Targeted Drugs for NSCLC Market: Squamous Cell Carcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 12. Targeted Drugs for NSCLC in Adenocarcinoma of NSCLC
Figure 13. Global Targeted Drugs for NSCLC Market: Adenocarcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 14. Targeted Drugs for NSCLC in Large Cell Carcinoma of NSCLC
Figure 15. Global Targeted Drugs for NSCLC Market: Large Cell Carcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 16. Global Targeted Drugs for NSCLC Market Size Market Share by Application in 2022
Figure 17. Global Targeted Drugs for NSCLC Revenue Market Share by Player in 2022
Figure 18. Global Targeted Drugs for NSCLC Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Targeted Drugs for NSCLC Market Size 2018-2023 ($ Millions)
Figure 20. APAC Targeted Drugs for NSCLC Market Size 2018-2023 ($ Millions)
Figure 21. Europe Targeted Drugs for NSCLC Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Targeted Drugs for NSCLC Market Size 2018-2023 ($ Millions)
Figure 23. Americas Targeted Drugs for NSCLC Value Market Share by Country in 2022
Figure 24. United States Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Targeted Drugs for NSCLC Market Size Market Share by Region in 2022
Figure 29. APAC Targeted Drugs for NSCLC Market Size Market Share by Type in 2022
Figure 30. APAC Targeted Drugs for NSCLC Market Size Market Share by Application in 2022
Figure 31. China Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Targeted Drugs for NSCLC Market Size Market Share by Country in 2022
Figure 38. Europe Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Figure 39. Europe Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Figure 40. Germany Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Targeted Drugs for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 54. APAC Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 55. Europe Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 57. United States Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 58. Canada Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 61. China Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 62. Japan Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 63. Korea Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 65. India Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 66. Australia Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 67. Germany Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 68. France Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 69. UK Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 70. Italy Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 71. Russia Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 72. Spain Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 75. Israel Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Targeted Drugs for NSCLC Market Size 2024-2029 ($ Millions)
Figure 78. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Application (2024-2029)
